ARS Pharmaceuticals' Neffy nasal spray showed 89.2% success in treating anaphylaxis in 545 patients, comparable to epinephrine injections. FDA approved Neffy in 2024 for adults and children over 30 kg ...
The U.S. Food and Drug Administration approved a new nasal spray on Friday to treat emergency allergic reactions in adults and children — the first injection-free alternative to shots like EpiPen. The ...
On Friday, the FDA approved ARS Pharmaceuticals Inc’s (NASDAQ:SPRY) neffy (epinephrine nasal spray) for the emergency treatment of allergic reactions (Type I), including those that are ...
Naloxone – also known as Narcan – is a medication that can reverse the effects of an opioid overdose. This includes heroin, fentanyl, and some types of painkillers. Paramedics and emergency room ...
A new study has found that a concentrated 2mg intranasal naloxone spray delivers naloxone as effectively, over the critical first 15 minutes, as the standard 0.4mg intramuscular (IM) naloxone ...
Please provide your email address to receive an email when new articles are posted on . Intranasal spray had faster and higher maximum concentrations than autoinjectors and manual syringes. The spray ...
Putting a vaccine directly into the nose may offer another kind of immunity, besides systemic immunity. China is one of the front-runners in the global race to develop a COVID-19 vaccine. Around eight ...
Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration approved a new nasal spray on Friday to treat emergency allergic reactions in adults and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results